CLUSTER filed Aug 3, 2026 at 17:32 ET
Two insiders at Entrada Therapeutics (Director Kush Parmar and 10% owner 5AM Ventures) sold a combined $1.59M in open-market sales over two days, representing ~0.6% of the company's $264M market cap. This is a significant cluster of selling by a director and a major venture holder, but the dollar amount is modest relative to market cap and the sales are likely part of a pre-arranged plan or liquidity event rather than a bearish signal. The stock has a strong analyst consensus (86% bullish) and recent insider activity includes $1.6M in sales over 30 days, suggesting a pattern of routine selling rather than a new negative development.